Bibliographic Info
Recommendation
Recommended in favor
Conditional
Certainty of evidence
Low
Reactive drug administration for reducing malaria transmission (2022): In areas approaching elimination or post-elimination settings preventing re-establishment of transmission, antimalarial medicine can be given as chemoprevention to all people residing with or near a confirmed malaria case and all people who share the same risk of infection (e.g. co-travellers and co-workers) to prevent or reduce malaria transmission.
Also Featured In
This recommendation also appears in the following guidelines:
WHO guidelines for malaria, 3 June 2022.
WHO guidelines for malaria, 25 November 2022.
WHO guidelines for malaria, 16 October 2023.
WHO Guidelines for malaria, 14 March 2023
WHO guidelines for malaria, 30 November 2024.